background
sever
acut
respiratori
syndrom
sar
newli
recogn
infecti
diseas
caus
outbreak
south
china
caus
sar
identifi
novel
coronaviru
cov
exist
asymptomat
seroconvertor
detect
sarscov
rna
plasma
cours
infect
suggest
sar
could
least
theoret
transmit
transfus
estim
risk
sar
transmiss
blood
transfus
contribut
decis
concern
blood
safeti
monitor
may
use
design
strategi
decreas
risk
transfusiontransmit
infect
studi
design
method
case
onset
date
shenzhen
sar
epidem
investig
result
taiwan
viremia
human
use
estim
number
case
virem
throughout
epidem
estim
asymptomatictoclin
confirm
sarscov
infect
ratio
proport
asymptomat
infect
report
seropreval
survey
hongkong
popul
size
shenzhen
use
infer
sarscov
transfusiontransmiss
risk
statist
resampl
method
use
result
base
data
shenzhen
hongkong
taiwan
maximum
mean
risk
per
million
sarscov
transmiss
donor
shenzhen
estim
ci
ci
respect
estim
risk
peak
april
conclus
although
current
confirm
report
transmiss
sarscov
asymptomat
individu
recent
research
data
indic
transfusiontransmit
sarscov
least
theoret
possibl
although
risk
low
rapid
spread
diseas
appear
alarmingli
high
infect
high
fatal
rate
public
health
author
need
consid
strategi
blood
donor
recruit
viru
inactiv
epidem
ensur
blood
safeti
theoret
estim
risk
sever
acut
respiratori
syndrom
transmiss
blood
transfus
epidem
shenzhen
guangdong
china
new
pathogen
antimicrobialresist
form
older
pathogen
continu
emerg
potenti
rapid
global
spread
high
morbid
mortal
three
exampl
pathogen
current
caus
human
health
concern
avian
influenza
virus
west
nile
viru
wnv
sever
acut
respiratori
syndrom
sar
coronaviru
sar
newli
describ
respiratori
infect
potenti
threat
health
peopl
throughout
world
etiolog
agent
novel
coronaviru
cov
sarsassoci
cov
sarscov
first
sar
case
identifi
foshan
municip
novemb
guangdong
gd
provinc
china
pattern
spread
sar
suggest
droplet
contact
transmiss
close
proxim
person
handl
human
secret
respiratori
secret
faec
like
enhanc
risk
transmiss
rel
high
transmiss
mortal
sar
rais
great
concern
public
health
epidemiolog
investig
show
total
probabl
case
death
report
countri
outbreak
data
august
world
health
organ
announc
last
chain
human
transfus
broken
juli
almost
everi
newli
emerg
human
pathogen
concern
safeti
blood
suppli
epidem
crisi
potenti
transmiss
sarscov
blood
blood
product
unknown
possibl
viremia
onset
clinic
symptom
andor
symptom
resolut
remain
import
concern
regard
blood
safeti
mildli
symptomat
asymptomat
infect
occur
document
seroconvers
healthcar
worker
hcw
anim
trader
april
drosten
et
al
report
viral
rna
detect
extrem
low
concentr
plasma
acut
symptomat
phase
infect
singapor
research
report
sarscov
detect
blood
infect
patient
also
woo
et
al
investig
rel
rate
nonpneumon
sarscov
infect
mildli
symptomat
infect
asymptomat
case
sarscov
pneumonia
taiwan
research
first
report
pattern
viremia
differ
among
differ
sar
patient
patient
protract
viremia
therefor
although
confirm
report
transmiss
sarscov
asymptomat
individu
unawar
sarscov
transmit
transfus
blood
compon
possibl
transmiss
donor
virem
phase
least
theoret
possibl
detect
nucleic
acid
amplif
nat
sarscov
blood
specimen
person
acut
infect
sarscov
report
number
patient
patient
mild
cours
sar
recov
approxim
day
develop
clinic
symptom
antibodi
sarscov
measur
patient
day
diseas
nat
may
therefor
way
identifi
patient
mild
symptom
earli
phase
diseas
might
nevertheless
virem
therefor
person
sar
could
potenti
virem
onset
symptom
andor
symptom
resolut
transmiss
sarscov
via
human
cell
tissu
cellular
tissuebas
product
hctp
recov
time
period
may
possibl
sar
occur
suddenli
disappear
quickli
howev
data
sar
viremia
prior
symptom
onset
rare
risk
estim
theoret
would
overestim
true
risk
viremia
develop
symptom
onset
use
seroepidemiolog
data
outbreak
sar
shenzhen
guangdong
provinc
china
estim
tempor
trend
proport
virem
asymptomat
individu
throughout
outbreak
use
statist
resampl
approach
scale
estim
estim
risk
transfusionassoci
sarscov
transmiss
outbreak
compar
result
estim
risk
base
data
taiwan
singapor
guangdong
center
diseas
control
cdc
supplement
data
former
estim
mainli
base
larg
epidemiolog
investig
done
woo
et
al
latter
estim
base
rel
small
scale
investig
describ
studi
popul
popul
shenzhen
guangdong
provinc
china
outbreak
guangdong
first
case
sar
identifi
follow
clinic
confirm
case
includ
death
confirm
case
live
shenzhen
first
estim
mani
infect
individu
known
symptom
onset
date
virem
time
point
throughout
outbreak
period
done
use
statist
resampl
approach
incorpor
symptom
onset
date
assum
distribut
length
time
onset
viremia
onset
symptom
estim
distribut
length
viremia
assum
distribut
durat
onset
viremia
symptom
onset
deriv
data
incub
period
sar
time
viremia
onset
rel
symptom
onset
incub
period
estim
distribut
durat
viremia
deriv
use
data
extens
seropreval
studi
mass
screen
detect
subclin
nonpneumon
infect
hongkong
assum
date
infect
individu
known
symptom
onset
date
similar
shenzhen
resid
becam
infect
year
use
estim
number
virem
case
time
infer
number
asymptomat
virem
sarscov
infect
popul
time
use
seroepidemiolog
survey
result
guangdong
cdc
hongkong
provid
estim
proport
sarscovinfect
individu
clinic
confirm
proport
asymptomat
sarscov
infect
final
use
popul
size
shenzhen
guangdong
provinc
http
wwwdemographiacom
scale
estim
number
virem
asymptomat
sarscov
infect
popul
estim
risk
probabl
sarscov
infect
blood
donat
onset
date
clinic
confirm
case
outbreak
obtain
shenzhen
municip
hospit
symptom
onset
time
day
case
shown
pin
plot
fig
time
correspond
februari
date
first
report
onset
time
correspond
last
report
onset
may
durat
epidem
thu
consid
day
wang
et
al
report
cours
sarscov
infect
viremia
human
use
result
obtain
plasma
time
infect
symptom
onset
incub
period
precis
known
seem
rel
short
approxim
report
incub
period
follow
maximum
likelihood
estim
mean
varianc
time
infect
onset
day
day
respect
ci
therefor
patient
would
experi
onset
symptom
within
day
infect
base
assumpt
incub
period
follow
gamma
distribut
approxim
lag
infect
viru
detect
viru
blood
durat
onset
viremia
symptom
onset
roughli
day
shorter
incub
period
effort
detect
sarscov
rna
plasma
cours
infect
found
highest
detect
rate
found
day
day
ill
analysi
sequenti
sarscov
load
plasma
six
case
reveal
differ
pattern
viremia
peak
day
day
calcul
infect
date
day
patient
diagnos
sar
use
sequenti
plasma
sampl
test
sarscov
infect
twentynin
sampl
test
mean
day
standard
deviat
day
viremia
describ
statist
method
use
formal
develop
along
line
method
use
found
method
develop
west
nile
viru
assum
rate
blood
donat
constant
cours
epidem
assum
potenti
blood
donor
risk
infect
sarscov
gener
popul
anticip
may
overestim
risk
latter
assumpt
base
find
serosurvey
healthi
blood
donor
conduct
hongkong
three
seroposit
identifi
final
assum
transfus
blood
compon
sarscov
infect
blood
donor
transmit
infect
recipi
effici
strategi
view
symptom
onset
time
case
n
anchor
time
use
inform
viremia
relat
symptom
onset
estim
number
case
viremia
time
outbreak
use
inform
inform
asymptomat
subclin
sarscov
infectiontoclin
confirm
sar
ratio
r
proport
infect
individu
remain
asymptomat
popul
size
estim
risk
sarscov
transmiss
transfus
unit
blood
donat
time
epidem
use
mont
carlo
simul
estim
number
asymptomat
virem
individu
fix
time
follow
individu
case
onset
time
record
day
discret
time
underli
infect
process
instead
continu
first
smooth
observ
case
onset
time
ad
smooth
compon
next
simul
viremia
time
span
comput
case
onset
viremia
rel
case
onset
time
chosen
take
random
sampl
assum
distribut
durat
infect
symptom
onset
base
histor
inform
provid
durat
viremia
chosen
take
random
sampl
replac
durat
time
data
obtain
taiwan
assum
procedur
rel
time
durat
viremia
case
independ
symptom
onset
time
next
reflect
uncertainti
r
random
deviat
r
gamma
distribut
mean
r
varianc
var
r
gener
case
simul
viremia
time
replic
r
time
reflect
number
virem
individu
popul
time
r
denot
largest
integ
r
subsequ
discount
viremia
time
symptomat
infect
account
uncertainti
random
deviat
beta
distribut
mean
varianc
var
gener
random
proport
replic
viremia
time
truncat
onset
time
end
run
number
viremia
time
occur
time
count
equal
space
grid
time
point
span
epidem
mont
carlo
sampl
process
repeat
time
result
count
number
asymptomat
virem
individu
time
grid
averag
graph
count
grid
point
time
yield
curv
repres
expect
number
asymptomat
virem
individu
cours
epidem
final
curv
divid
popul
size
potenti
donor
yield
estim
risk
probabl
sarscov
transfus
transmiss
popul
size
potenti
donor
estim
total
popul
size
shenzhen
approxim
popul
least
year
age
http
access
decemb
call
result
curv
expect
risk
curv
erc
assum
possibl
sar
infect
donor
whole
elig
popul
comput
two
summari
measur
erc
aid
interpret
maximum
valu
mean
valu
durat
epidem
maximum
simpli
point
curv
highest
time
maximum
estim
expect
transfusionassoci
sarscov
risk
highest
mean
comput
divid
area
erc
durat
epidem
provid
measur
expect
transmiss
risk
whole
cours
epidem
confid
band
true
risk
curv
trc
around
erc
comput
variou
way
use
simultan
percentilet
approach
detail
outlin
ci
true
maximum
read
confid
band
trc
ci
true
mean
comput
use
percentilet
approach
similar
trc
rel
littl
avail
inform
epidemiolog
sar
sarscov
infect
perform
second
analys
use
differ
sourc
data
key
paramet
model
approach
addit
analysi
report
second
analysi
use
data
drawn
singapor
guangdong
cdc
r
var
r
var
singapor
studi
wildersmith
et
al
report
hospit
staff
posit
sarscov
serolog
sarscovposit
studi
particip
classifi
pneumon
sar
subclin
sar
asymptomat
sarscov
infect
guangdong
cdc
found
one
seroposit
adult
healthi
adult
studi
clinic
comput
perform
statist
softwar
splu
version
insight
corpor
seattl
wa
usa
use
either
builtin
function
function
written
one
author
bjb
five
thousand
simul
combin
produc
erc
shown
dark
solid
line
fig
dash
line
percentilet
simultan
confid
band
also
shown
fig
randomli
select
realiz
erc
gener
scale
left
axi
risk
per
million
sarscov
transmiss
transfus
singl
unit
blood
result
display
fig
estim
base
estim
obtain
woo
et
al
result
secondari
analysi
report
tabl
use
given
valu
r
although
donor
screen
test
nearli
elimin
risk
transfusionacquir
infect
attribut
hiv
hepat
virus
potenti
emerg
spread
pathogen
particularli
associ
asymptomat
ill
could
result
unrecogn
transmiss
blood
transfus
result
indic
small
nonzero
risk
sarscov
transmiss
transfus
blood
compon
epidem
least
theoret
base
data
differ
publish
literatur
calcul
epidem
sar
shenzhen
risk
peak
approxim
per
million
donat
late
marchearli
april
mean
risk
cours
outbreak
per
million
donat
calcul
risk
highli
limit
time
nearzero
zero
risk
among
donat
februari
august
time
report
commun
sarscov
transmiss
shenzhen
guangdong
china
donat
shenzhen
time
epidem
base
averag
risk
estim
per
million
donat
expect
number
infect
donat
base
simpl
binomi
model
probabl
least
one
infect
donat
donat
made
roughli
ratio
r
crucial
factor
risk
estim
approach
tabl
clear
estim
sensit
assumpt
quantiti
good
epidemiolog
data
strengthen
infer
improv
understand
epidemiolog
sar
provid
opportun
refin
estim
report
blood
safeti
surveil
emphas
exist
subclin
nonpneumon
sarscov
infect
sinc
person
sever
symptom
would
less
like
donat
blood
comparison
differ
estim
report
tabl
show
almost
peak
risk
time
april
line
govern
report
outbreak
estim
time
peak
risk
driven
case
onset
time
realli
affect
specif
r
result
expect
consist
sar
epidem
broadli
rampant
march
april
may
mainland
china
estim
mean
transmiss
risk
per
million
may
high
sever
reason
assum
rate
transmiss
virem
donor
true
rate
probabl
lower
also
uncertainti
durat
viremia
hand
use
total
popul
shenzhen
person
age
yr
yr
denomin
risk
estim
true
number
potenti
donor
probabl
lower
expect
underestim
true
risk
furthermor
populationbas
seroepidemiolog
data
avail
inform
specif
asymptomat
rate
relev
paramet
use
model
approach
estim
use
variou
paramet
model
best
avail
bias
bias
would
directli
impact
result
took
care
analys
use
avail
relev
publish
data
imposs
without
possibl
populationbas
estim
adjust
unknown
bias
sensit
analysi
show
valu
assum
particularli
r
critic
result
obtain
sinc
data
singapor
base
rel
small
sampl
healthcar
worker
data
hongkong
base
extens
seropreval
studi
mass
screen
detect
subclin
nonpneumon
infect
consid
primari
result
base
valu
r
obtain
woo
et
al
even
confirm
case
sarscov
transmiss
blood
transfus
sever
precautionari
measur
implement
chines
blood
center
spring
prevent
potenti
risk
sarscov
transmiss
blood
measur
includ
new
question
ad
donor
questionnair
predon
contact
histori
suspect
sar
patient
peopl
contact
histori
sar
normal
bodi
temperatur
ad
criterion
donor
qualif
donor
requir
notifi
blood
collect
facil
fever
cough
suspect
sar
symptom
occur
within
two
week
donat
sarscov
antibodi
test
research
project
soon
start
use
avail
test
donor
sampl
kumar
humar
report
transplant
patient
uniqu
predispos
emerg
infect
appli
sar
lesson
learn
west
nile
viru
sarscov
transplant
applic
futur
outbreak
emerg
infecti
diseas
meantim
basi
current
knowledg
return
sar
rule
particularli
origin
viru
assum
civet
cat
could
quarantin
furthermor
exist
asymptomat
sarscov
infect
detect
sarscov
rna
plasma
cours
infect
suggest
transmiss
sarscov
transfus
least
theoret
possibl
analys
suggest
howev
probabl
low
outbreak
similar
magnitud
one
shenzhen
maximum
estim
risk
per
million
donat
case
sar
recur
prevent
measur
consid
epidem
includ
strategi
blood
donor
recruit
estim
provid
herein
may
use
quantit
evalu
measur
quantif
effect
like
avail
unless
sar
recur
